Literature DB >> 20195700

Factors affecting prognosis of patients with intracranial anaplastic oligodendrogliomas: a single institutional review of 70 patients.

Liu-song Yang1, Feng-ping Huang, Kang Zheng, Hai-shi Zhang, Xiang Zhou, Xu-hui Bao, Jia-jun Zheng, Chuan Chang, Liang-fu Zhou.   

Abstract

Anaplastic oligodendroglioma (AO) is an uncommon intracranial tumor and prognosis is poor. In this study, we assessed the factors affecting the prognosis of AO patients. Seventy AO patients were recruited from 2001 to 2006 in Shanghai Huashan Hospital of Fudan University; all were treated surgically. Kaplan-Meier survival analysis and Cox regression analysis were used to analyze the prognostic effects of 14 different factors, which were selected from clinical, radiological, pathological, and treatment variables. The results showed that chemotherapy, age, primary or secondary tumors, preoperative Karnofsky Performance Scale (KPS) scores, the presence of epilepsy at initial presentation, radiological contrast infusion, and neurological parameters all correlated with the prognosis of the patients. Furthermore, Cox multivariate analysis also showed that the age (P < 0.048), primary or secondary tumors (P < 0.010), and chemotherapy (P < 0.010) were significantly correlated with the prognosis of the patients. Age and chemotherapy correlated with the prognosis of AO. The patients younger than 50 years old and who received regular chemotherapy were likely to achieve a good outcome. Moreover, individualized treatment after molecular biological typing of AO may improve the prognosis of AO.

Entities:  

Mesh:

Year:  2010        PMID: 20195700     DOI: 10.1007/s11060-010-0146-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  19 in total

1.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

Authors:  J S Smith; A Perry; T J Borell; H K Lee; J O'Fallon; S M Hosek; D Kimmel; A Yates; P C Burger; B W Scheithauer; R B Jenkins
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

Review 2.  Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.

Authors:  D Fortin; G J Cairncross; R R Hammond
Journal:  Neurosurgery       Date:  1999-12       Impact factor: 4.654

3.  Oligodendroglioma: an analysis of prognostic factors and treatment results.

Authors:  A Allam; A Radwi; A El Weshi; M Hassounah
Journal:  Am J Clin Oncol       Date:  2000-04       Impact factor: 2.339

4.  Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Authors:  Y Ino; R A Betensky; M C Zlatescu; H Sasaki; D R Macdonald; A O Stemmer-Rachamimov; D A Ramsay; J G Cairncross; D N Louis
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

Review 5.  Oligodendroglioma: pathology and molecular biology.

Authors:  Herbert H Engelhard; Ana Stelea; Elizabeth J Cochran
Journal:  Surg Neurol       Date:  2002-08

Review 6.  Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology.

Authors:  Guido Reifenberger; David N Louis
Journal:  J Neuropathol Exp Neurol       Date:  2003-02       Impact factor: 3.685

7.  Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.

Authors:  Vinay K Puduvalli; Masood Hashmi; Leslie D McAllister; Victor A Levin; Kenneth R Hess; Michael Prados; Kurt A Jaeckle; W K Alfred Yung; Saundra S Buys; Janet M Bruner; Jeannette J Townsend; Richard Davis; Raymond Sawaya; Athanassios P Kyritsis
Journal:  Oncology       Date:  2003       Impact factor: 2.935

8.  Oligodendroglioma: the Rotterdam-Dijkzigt experience.

Authors:  J M Kros; H Pieterman; C G van Eden; C J Avezaat
Journal:  Neurosurgery       Date:  1994-06       Impact factor: 4.654

9.  A multivariate analysis of the prognostic factors of grade III gliomas.

Authors:  Yong-jian Zhu; Xiang-dong Zhu; Sheng-hu Wang; Fang Shen; Hong Shen; Wei-guo Liu
Journal:  Chin Med J (Engl)       Date:  2008-06-20       Impact factor: 2.628

Review 10.  Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis.

Authors:  Herbert H Engelhard; Ana Stelea; Arno Mundt
Journal:  Surg Neurol       Date:  2003-11
View more
  7 in total

1.  Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients.

Authors:  Jacob Y Shin; Aidnag Z Diaz
Journal:  J Neurooncol       Date:  2016-07-11       Impact factor: 4.130

2.  Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.

Authors:  Shouwei Li; Changxiang Yan; Lei Huang; Xiaoguang Qiu; Zhongcheng Wang; Tao Jiang
Journal:  Neuro Oncol       Date:  2011-10-27       Impact factor: 12.300

3.  Extent of resection and survival for oligodendroglioma: a U.S. population-based study.

Authors:  Connor J Kinslow; Andrew L A Garton; Ali I Rae; Logan P Marcus; Christopher M Adams; Guy M McKhann; Michael B Sisti; E Sander Connolly; Jeffrey N Bruce; Alfred I Neugut; Adam M Sonabend; Peter Canoll; Simon K Cheng; Tony J C Wang
Journal:  J Neurooncol       Date:  2019-08-12       Impact factor: 4.130

4.  Stereotactic interstitial brachytherapy for the treatment of oligodendroglial brain tumors.

Authors:  Faycal El Majdoub; Clemens Neudorfer; Tobias Blau; Martin Hellmich; Christian Bührle; Martina Deckert; Volker Sturm; Mohammad Maarouf
Journal:  Strahlenther Onkol       Date:  2015-08-26       Impact factor: 3.621

5.  Peritumoral edema on magnetic resonance imaging predicts a poor clinical outcome in malignant glioma.

Authors:  Chen-Xing Wu; Guo-Shi Lin; Zhi-Xiong Lin; Jian-Dong Zhang; Long Chen; Shui-Yuan Liu; Wen-Long Tang; Xian-Xin Qiu; Chang-Fu Zhou
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

6.  Exploring the relationship between age and prognosis in glioma: rethinking current age stratification.

Authors:  Zetian Jia; Xiaohui Li; Yaqi Yan; Xuxuan Shen; Jiuxin Wang; He Yang; Shuo Liu; Chengxi Han; Yuhua Hu
Journal:  BMC Neurol       Date:  2022-09-15       Impact factor: 2.903

Review 7.  Clinical management of grade III oligodendroglioma.

Authors:  G Simonetti; P Gaviani; A Botturi; A Innocenti; E Lamperti; A Silvani
Journal:  Cancer Manag Res       Date:  2015-07-27       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.